Tag: Myriad
Myriad Genetics CEO Paul J. Diaz to Present at Goldman Sachs...
SALT LAKE CITY, June 04, 2021 (GLOBE NEWSWIRE) -- Paul J. Diaz, president and CEO of Myriad Genetics (NASDAQ: MYGN), a...
Myriad Genetics Signs Definitive Agreement to Sell Myriad RBM to...
SALT LAKE CITY, May 24, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision...
Myriad Genetics Appoints Melissa Gonzales to Lead Women’s Health Business
SALT LAKE CITY, May 20, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision...
Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing...
SALT LAKE CITY, May 03, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision...
Myriad Genetics Signs Definitive Agreement to Sell Myriad myPath® Melanoma,...
SALT LAKE CITY, April 27, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision...
Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity...
SALT LAKE CITY, March 29, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision...